Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EPN2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PRX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CSMD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KNCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ABCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEF1E1-BLOC1S5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMPACT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927537 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC18A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100653137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFMBT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on